Navigating Hypoparathyroidism: Understanding the Multisystem Burden and Optimizing Patient Care - Episode 2
Diagnosing Hypoparathyroidism and Establishing a Multisystem Baseline
In this episode, Dr. Cusano asks Dr. Lubitz to walk through the diagnostic approach to hypoparathyroidism, followed by Dr. Khosravi on establishing a multisystem baseline after diagnosis.
Dr. Lubitz defines hypoparathyroidism as a low or inappropriately normal PTH in the presence of hypocalcemia—confirmed by albumin-corrected serum calcium or ionized calcium on at least two occasions at least two weeks apart. Chronic disease is defined by persistence beyond one year. The initial workup should also include magnesium, phosphorus, 24-hour urine calcium, kidney function, and genetic testing for non-surgical patients or those under age 40. Common diagnostic delays arise from nonspecific symptoms like brain fog, a PTH in the low-normal range that is nonetheless inappropriate given the degree of hypocalcemia, uncorrected magnesium disorders—the only reversible cause of hypoparathyroidism—and biotin supplementation interfering with the PTH immunoassay.
Dr. Khosravi then explains that the baseline evaluation must be tailored to each patient. For the kidneys, the minimum workup includes serum calcium, phosphorus, 25-hydroxyvitamin D, magnesium, urinary calcium, and creatinine, with a broader urinary panel and baseline renal ultrasound for patients with prior nephrolithiasis or nephrocalcinosis. For the skeleton, DEXA is recommended for postmenopausal women and men over 50, along with vertebral fracture assessment, particularly in non-surgical patients. For neuropsychiatric health, validated quality-of-life instruments such as the SF-36 and hypoparathyroidism-specific questionnaires should be completed at baseline, with attention to depression, anxiety, and seizure history. Basal ganglia calcifications are common in non-surgical forms. A baseline EKG is recommended, especially for non-surgical patients, and multigene panel testing is valuable in genetic cases. Dr. Cusano emphasizes that quality-of-life assessment and 24-hour urine calcium measurement are frequently overlooked in routine practice.
In the next episode, "Quality of Life in Hypoparathyroidism: Burden Across Four Domains," Dr. Ferenczi describes how hypoparathyroidism impairs physical functioning, cognition, psychological wellbeing, and daily social life, and reviews the validated tools clinicians use to measure these effects.
